Abstracts tagged "Communication"

Abstract Number: 1255 • 2017 ACR/ARHP Annual Meeting
Using PROs to Guide Patient-Centered Conversations and Care in Inflammatory Arthritis: The Clinician Perspective
Susan J. Bartlett¹, Katherine Clegg Smith², Elaine de Leon², Michelle Jones³, Anna Kristina Gutierrez⁴, Allie Butanis⁵ and Clifton O. Bingham III⁶, ¹Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, ²Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, ³Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁵Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD, ⁶Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: Although patient-reported outcomes (PROs) are routinely collected for research and quality purposes, they have not been routinely incorporated into the routine care of patients.…
Abstract Number: 1260 • 2017 ACR/ARHP Annual Meeting
Lupus Diagnosis: Process and Patient Experience
Rossi Daly, Roushanac Partovi and Patricia Davidson, Lupus Foundation of America, Washington, DC
Background/Purpose: Delays in lupus diagnosis and misdiagnosis are sources of concern, as uncontrolled disease activity and early damage can increase mortality risk.1 The purpose of…
Abstract Number: 1385 • 2017 ACR/ARHP Annual Meeting
Decisional Conflict in Doctor – Patient Discussions about Disease Modifying Anti-Rheumatic Drugs
Rohit Nallani¹ and Richard W Martin², ¹Michigan State University, College of Human Medicine, Grand Rapids, MI, ²Medicine, Rheumatology, Michigan State University, College of Human Medicine, Grand Rapids, MI
Background/Purpose: There are few published studies describing patient-physician discussions about initiating new rheumatoid arthritis (RA) medications in real world settings. The purpose of this study…
Abstract Number: 1860 • 2017 ACR/ARHP Annual Meeting
A Trial Testing Strategies to Enhance Patient Understanding of Drug Information: Experience Recruiting Subjects through an Online Patient Community
Susan J. Blalock¹, Elizabeth Solow², W. Benjamin Nowell³, Steven Woloshin⁴, Lisa Schwartz⁴, Delesha M. Carpenter⁵, Jeffrey R. Curtis⁶, Larry W. Moreland⁷, Caprice Hunt¹, Genevieve Hickey¹ and Valerie Reyna⁸, ¹Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, ²Internal Medicine, Univesity of Texas Southwestern Medical Center, Dallas, TX, ³CreakyJoints/Global Health Living Foundation, Upper Nyack, NY, ⁴Geisel School of Medicine, Dartmouth, Hanover, NH, ⁵Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Asheville, NC, ⁶Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁷Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ⁸Cornell University, Ithica, NY
Background/Purpose: Current guidelines for the treatment of rheumatoid arthritis (RA) underscore the importance of an early and targeted approach to control inflammation. We describe initial…
Abstract Number: 2255 • 2017 ACR/ARHP Annual Meeting
Using PROs to Guide Patient-Centered Conversations and Care in Inflammatory Arthritis: The Patient Perspective
Clifton O. Bingham III¹, Katherine Clegg Smith², Elaine de Leon², Michelle Jones³, Anna Kristina Gutierrez⁴, Allie Butanis⁵ and Susan J. Bartlett⁴, ¹Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, ³Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁵Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD
Background/Purpose: Although optimal care is patient-centered and grounded in shared decision-making (SDM) between patients and providers, rheumatologists often have little insight into the day-to-day experiences…
Abstract Number: 2469 • 2016 ACR/ARHP Annual Meeting
How Rheumatoid Arthritis Patients and Rheumatologists Communicate during Clinic Visits When a New DMARD Is Prescribed
Lorie L. Geryk¹, Susan J. Blalock², Courtney A. Roberts², Beth L. Jonas³ and Delesha M. Carpenter⁴, ¹Division of Pharmaceutical Outcomes and Policy, University of North Carolina, Chapel Hill, NC, ²Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, ³Thurston Arthritis Research Ct, University of North Carolina Thruston Arthritis Research Center, Chapel Hill, NC, ⁴Division of Pharmaceutical Outcomes and Policy, University of North Carolina, Asheville, NC
Background/Purpose: This observational study includes data from clinic visits of 38 RA patients (3 rheumatologists) that occurred in a southeastern state from May 2014 to…
Abstract Number: 566 • 2016 ACR/ARHP Annual Meeting
Rheumatoid Arthritis Patients’ Ability to Accurately Recall DMARD Information Immediately Following an Office Visit with Their Rheumatologist
Delesha Carpenter¹, Lorie Geryk², Courtney Roberts², Beth L. Jonas³ and Susan J. Blalock⁴, ¹Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Asheville, NC, ²Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, ³Thurston Arthritis Research Ct, University of North Carolina Thruston Arthritis Research Center, Chapel Hill, NC, ⁴Eshelman School of Pharmacy, UNC at Chapel Hill, Chapel Hill, NC
Background/Purpose: Patient misunderstandings about DMARDs may contribute to nonadherence. We present longitudinal observational data regarding whether patients can accurately recall medication information about a newly-prescribed…
Abstract Number: 1057 • 2016 ACR/ARHP Annual Meeting
Effect of Quantitative Information Concerning Medication Side-Effects on Risk Perception
Susan J. Blalock¹ and Matthew Dixon², ¹Eshelman School of Pharmacy, UNC at Chapel Hill, Chapel Hill, NC, ²Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, Namibia
Background/Purpose: The Food and Drug Administration (FDA) requires that patients prescribed a bisphosphonate to treat osteoporosis receive an FDA-approved Medication Guide that warns of the…
Abstract Number: 2329 • 2015 ACR/ARHP Annual Meeting
Describe Treatments As ‘new’ or ‘old’ at Your Peril: Influences on Patient Decision Making
Mark Harrison^1,2, Carlo Marra³ and Nick Bansback^4,5, ¹Faculty of Pharmaceutical Sciences, Vancouver, BC, Canada, ²Centre for Health Evaluation and Outcomes Sciences, St Paul's Hospital, Vancouver, BC, Canada, ³School of Pharmacy, Memorial University, St John's, NF, Canada, ⁴St. Paul's Hospital, Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada, ⁵School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Using an example of a new drug for rheumatoid arthritis which offers comparable effectiveness and side-effect point estimates to older drugs, we explore preferences…
Abstract Number: 2338 • 2015 ACR/ARHP Annual Meeting
“It Was like No One Is Listening to Me”�: A Qualitative Study of the Lived Experiences of Patients with Rheumatoid Arthritis in the Setting of Patient-Physician Discordance in Assessments of Disease Activity
John M. Davis III¹, Zoran Kvrgic², Melissa M. Plagge¹, Jennifer L. Ridgeway³ and Gladys B. Asiedu³, ¹Division of Rheumatology, Mayo Clinic, Rochester, MN, ²Rheumatology, Mayo Clinic, Rochester, MN, ³Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN
Background/Purpose: Discordance between patients with rheumatoid arthritis (RA) and their rheumatologists in their global assessments of disease activity affects around 33% of clinical encounters. The…
Abstract Number: 2500 • 2015 ACR/ARHP Annual Meeting
Impact of Health Portal Enrollment and Electronic Appointment Reminders to Improve Appointment Attendance at an Academic Rheumatology Clinic
Arielle Mendel¹ and Shirley Chow², ¹Medicine, University of Toronto, Toronto, ON, Canada, ²Division of Rheumatology, University of Toronto, Toronto, ON, Canada
Background/Purpose: ‘No-shows’ (NS) to ambulatory care reduce the quality and efficiency of healthcare delivery. We sought to identify patient, provider, and system factors associated with…
Abstract Number: 2634 • 2015 ACR/ARHP Annual Meeting
Associations Between Health Literacy, Ethnicity, Communication Quality and Beliefs about Medicines in Rheumatoid Arthritis
Jennifer Barton^1,2, Patricia P. Katz³, Laura Trupin⁴, Somnath Saha⁵, Dean Schillinger⁶ and Edward H. Yelin⁴, ¹VA Portland Health Care System, Portland, OR, ²Medicine/Rheumatology, Oregon Health & Science University, Portland, OR, ³Rheumatology, UCSF, SF, CA, ⁴University of California, San Francisco, San Francisco, CA, ⁵Medicine, VA Portland Health Care System, Portland, OR, ⁶Medicine, UCSF, San Francisco, CA
Background/Purpose: Vulnerable populations with rheumatoid arthritis (RA) experience poorer health outcomes despite access to current therapies. These disparities may result from limited health literacy, cultural…
Abstract Number: 2898 • 2014 ACR/ARHP Annual Meeting
New Insights into the Primary Care Osteoarthritis Consultation with Implications for Practice
Zoe Paskins¹, Tom Sanders¹, Peter Croft¹ and Andrew Hassell², ¹Research Institute for Primary Care and Health Sciences, Keele University, Keele, United Kingdom, ²School of Medicine, Keele University, Keele, United Kingdom
Background/Purpose Osteoarthritis (OA) is the commonest long term condition in primary care. Existing international guidance suggests that much can be done to improve patient outcomes…
Abstract Number: 2405 • 2014 ACR/ARHP Annual Meeting
Quality of Patient- Clinician Communication in a Diverse Cohort of Adults with Rheumatoid Arthritis
Jennifer Barton¹, Chris Tonner², Laura Trupin¹, Patricia P. Katz³ and Edward H. Yelin⁴, ¹Medicine, University of California, San Francisco, San Francisco, CA, ²3333 California Street, Box 09, University of California, San Francisco, San Francisco, CA, ³Medicine, University of California, San Francisco, CA, ⁴Arthritis Research Group, University of California, San Francisco, San Francisco, CA
Background/Purpose: To assess correlates of the quality of patient-clinician communication in a diverse cohort of adults with rheumatoid arthritis (RA). Methods: Data were obtained through…
Abstract Number: 2011 • 2014 ACR/ARHP Annual Meeting
What Do State Legislators Think about Arthritis? Results of Focus Groups with State Legislators
Mari Brick¹, Erica Odom², Teresa J. Brady³, Carol McPhillips-Tangum⁴, Angela Oliver², Dana Heyl⁵ and Jennifer Hefelfinger⁶, ¹National Association of Chronic Disease Directors, Voorheesville, NY, ²Centers for Disease Control and Prevention, Atlanta, GA, ³Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ⁴Experion HealthCare Group LLC, Atlanta, GA, ⁵Consultant, Atlanta, GA, ⁶National Association of Chronic Disease Directors, Atlanta, GA
Background/Purpose: Arthritis affects > 1 in 5 American adults, and is the most common cause of disability. Nearly ½ of people with diabetes or heart…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].